Dollars for Docs Media Roundup
Tonight, the Nightly Business Report will air part two of their report on our “Dollars for Docs” investigation in which we detailed pharmaceutical companies’ payments to doctors. (Look up your doctor.) Tonight’s segment will feature ProPublica senior reporter Tracy Weber discussing some of the doctors who received payments to promote drugs. Check here to find local airtimes.
Yesterday, Charles Ornstein explained to NPR’s Morning Edition’s Renee Montagne how the project could help empower patients. And Weber spoke with All Things Considered’s Robert Siegel and told him how we analyzed the database to piece together the story. NPR will have more on this series in the coming days.
ProPublica in the News
- 100 great things about America
- How ProPublica changed investigative reporting
- In Praise of ProPublica
- Making a market: How ProPublica blends news that wins Pulitzers with news that wins followers
- Scott Klein: News apps don't just tell a story, they tell your story
- ProPublica's outreach a welcome step toward "open-source" journalism
Latest Press Releases
ProPublica Reports
Get Our Data and Reporting Tools
We frequently publish data, and reporting tools like tipsheets and guides.
Our Hottest Stories
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- On Victory Drive, Soldiers Defeated by Debt
- The Most Important #Muckreads on Rape in the Military
- Everything We Know About What’s Happened Under Sequestration
- The Story Behind Our Hospital Interactive
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Lifting the Veil on Dangerous Prescribing
- FAQ: What You Need to Know About Prescriber Checkup
- IRS Office That Targeted Tea Party Also Disclosed Confidential Docs From Conservative Groups
- The 182 Percent Loan: How Installment Lenders Put Borrowers in a World of Hurt
- Everything We Know About What’s Happened Under Sequestration
- On Victory Drive, Soldiers Defeated by Debt
- Medicare Drug Program Fails to Monitor Prescribers, Putting Seniors and Disabled at Risk
- How the IRS’s Nonprofit Division Got So Dysfunctional
- Is Obama Delivering on His Promise of a “21st Century” Approach to Drugs?
- Intern vs. Mayor: Battle Bares Bloomberg's Argument for Secrecy
- The Most Important #Muckreads on Rape in the Military
- How We Analyzed Medicare’s Drug Data
1 comments
Bob Aller
Sept. 10, 2011, 4:34 p.m.
While it’s a step forward to have pharmaceutical companies list payments to doctors, it’s also crucial for the pharmaceuticals to describe what services the doctor rendered for the payment. If the doc gave a talk, what was the talk about? Without having that piece of the puzzle, the consumer is still very much in the dark and the specificity of potential conflicts-of-interest remain hidden.
I’d appreciate any illuminating comments on this topic as I’m new to it and only just read the excellent piece by Charles Ornstein and Tracy Weber.
Thanks. Bob